Home

Articles

  1. Lehrer S. Glioblastoma and dementia may share a common cause. Med Hypotheses Feb 22, 2010, Epub ahead of print. pdf

  2. Lehrer S. Anopheles mosquito transmission of brain tumor. Med Hypotheses 2010;74(1):167-168. pdf

  3. Lehrer S, André Montazem, Lakshmi Ramanathan, Melissa Pessin-Minsley, John Pfail, Richard G. Stock, Rita Kogan. Bisphosphonate-Induced Osteonecrosis of the Jaws, Bone Markers, and a Hypothesized Candidate Gene. J Oral Maxillofacial Surgery 2009; 67(1):159-161 pdf

  4. Lehrer S. Inhaled insulin for the early detection of lung cancer. Med Hypotheses. 2008;71(4)615-616. pdf

  5. Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Sep;106(3):389-91. Epub 2008 Jun 13. pdf

  6. Lehrer, S. Statin use to prevent aromatase inhibitor-induced fracture and cardiovascular complications. Med Hypotheses. 2007;68(6)1417. Epub 2006 Dec 29. pdf

  7. Lehrer S, Cesaretti J, Stone NN, Stock RG. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation. BJU Int. 2006 Nov;98(5):979-81. pdf

  8. Lehrer S, Diamond EJ, Stone NN, Stock RG. Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer. BJU Int. 2005; 96, 328–329. pdf

  9. Lehrer S, Diamond EJ, Mamkine B, Droller MJ, Stone NN and Stock RG. C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer. BJU Int. 2005; 95, 961–962. pdf

  10. Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):196-202. pdf

  11. Lehrer S, Stone NN, Stock RG. Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy. 2005; J Urol 173:79-81. pdf

  12. Lehrer S, Diamond EJ, Mamkine B, Stone NN, Stock RG. Serum interleukin-8 is elevated in men with prostate cancer and bone metastases. Technology in Cancer Research & Treatment. 2004; 3(5):411-412.  pdf

  13. Lehrer S, Roboz J, Ding H, Zhao S, Diamond EJ, Holland JF, Stone NN, Droller MJ, Stock RG. Putative protein markers in the sera of men with prostatic neoplasms. BJU Int 2003 Aug;92(3):223-5.  pdf

  14. Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG, Stone M, Bajwa A, Kornreich R. Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene. Urol Oncol 2003 Mar-Apr;21(2):101-4. pdf

  15. Lehrer S, Diamond EJ, Droller MJ, Stone NN, Stock RG. Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002 Dec 18;94(24):1893. pdf

  16. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer. Br J Cancer 2002 Sep 23;87(7):726-8. pdf

  17. Lehrer S. Reply: Prostate cancer, insulin and androgen deprivation therapy. Br J Cancer 2003 Nov 3;89(9):1815. pdf

  18. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Increased serum insulin associated with increased risk of prostate cancer recurrence. The Prostate 2002;50:1-3. pdf

  19. Lehrer S, Stone NN, Droller MJ, Stock RG. Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer. Urol Oncol 2002;7(2):73-76. pdf

  20. Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG. Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. Journal of Urology 2002;168:2431-2433. pdf

  21. Lehrer S, Diamond EJ, Bajwa AW, Kornreich R, Stagger S, Stone NN, Droller MJ, Stock RG. Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer. Prostate Cancer and Prostatic Diseases 2001;4:232-234. pdf

  22. Lehrer S, McCurdy LD, Stock RG, Kornreich R, Stone NN, Eng C. Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients. Cancer Genet Cytogenet 2000;122:131-133. pdf

  23. Lehrer S. Re: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 1998;159:1311. pdf

  24. Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK, McGovern M. Absence of 185delAG mutation of the BRCA1 gene and 617delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Brit J Cancer 1998;78(6):771-773. pdf

  25. Lehrer S. Possible relationship of the apolipoprotein E (ApoE) epsilon4 allele to prostate cancer. Br J Cancer 1998;78:1398. pdf

  26. Lehrer S. Pregnancy termination and risk of breast cancer. JAMA 1996;276:31-2. pdf

  27. Lehrer S, Terk M, Piccoli SP, Song HK, Lavagnini P, Luderer AA. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 1996;74:871-873. pdf

  28. Brower ST, Tartter P, Weiss S, Luderer AA, Lehrer S. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors. Mt Sinai J Med 1995;62:419-21. pdf

  29. Brower ST, Tartter P, Weiss S, Luderer AA, Lehrer S. Reproductive history and prognosis in patients with operable breast cancer. Cancer 1995;76:531-532. pdf

  30. Lehrer S, Lee P, Tartter P, Shank B, Brower ST. Breast cancer and family history: a multivariate analysis of levels of tumor HER2 protein and family history of cancer in women who have breast cancer. Mt Sinai J Med 1995;62:415-8. pdf

  31. Lehrer S, Garey J, Shank B. Nomograms for determining the probability of axillary node involvement in women with breast cancer. J Cancer Res Clin Oncol 1995;121:123-125. pdf

  32. Berkowitz GS, Stone JL, Lehrer SP, Marcus M, Lapinski RH, Schachter BS. An estrogen receptor genetic polymorphism and the risk of primary and secondary recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171(6):1579-1584.  pdf

  33. Garey J, Lehrer S. Adjuvant therapy for breast cancer. N Engl J Med 1994;331(11):742-743. pdf

  34. Lehrer S, Harlap S, Rabin J, Schachter BS. Estrogen receptor polymorphism, spontaneous abortion, and breast cancer risk. Int J Oncol 1994;5:861-864. abstract  pdf

  35. Lehrer S. Fostering young investigators [letter]. Science 1994;266:954 pdf

  36. Lehrer S, Song HK. Nomogram for predicting the risk of node involvement in prostate cancer, given pretreatment prostate-specific antigen and Gleason score [letter]. Int J Radiat Oncol Biol Phys 1994;30:509-510. pdf

  37. Lehrer S. Tubal ligation, hysterectomy, and risk of ovarian cancer [letter; comment]. JAMA 1994;271:1236. pdf

  38. Lehrer S, Bogursky E, Yemini M, Kase NG, Birkenfeld A. Gynecologic manifestations of Sjogren's syndrome. Am J Obstet Gynecol 1994;170:835-837. pdf

  39. Lehrer S, Rabin J, Stone J, Berkowitz GS. Association of an estrogen receptor variant with increased height in women. Horm Metab Res 1994;26:486-488. pdf

  40. Schachter BS, Lehrer S. Re: "Risk of miscarriage and a common variant of the estrogen receptor gene" [letter]. Am J Epidemiol 1994;140:1144-1145. pdf

  41. Lehrer S, Segna R, Dottino P, Cohen C. Lipid associated sialic acid in plasma (LASA-P), plasma DM/70K, tumor epidermal growth factor and tumor DNA index in women with ovarian cancer. Int J Oncol 1993;2:95-96. abstract  pdf

  42. Lehrer S, Rabin J, Kalir T, Schachter B. Estrogen receptor variant and hypertension in women. Hypertension 1993;21:439-441. pdf  citations

  43. Lehrer S, Lee P, Tartter P, Brower S. Tumour HER2 protein in breast cancer and family history. Lancet 1993;341:1420-1421. pdf

  44. Lehrer S, Stone J, Lapinski R, Lockwood CJ, Schachter BS, Berkowitz R, Berkowitz GS. Association between pregnancy-induced hypertension and asthma during pregnancy. Am J Obstet Gynecol 1993;168(5):1463-1466. pdf

  45. Lehrer S. Reply to Fossati et al. Cancer 1993;71(3):877

  46. Lehrer SP, Schmutzler RK, Rabin JM, Schachter BS. An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Res Treat 1993;26:175-180. pdf

  47. Lehrer S, Levine E, Savoretti P, Cropley J, Botstein C, Song HK, Mandell L, Shank B. Past pregnancy is associated with axillary node involvement in women with breast cancer. Cancer 1992;69:981-983. pdf

  48. Lehrer S, Levine E, Savoretti P, Cropley J, Dalton J, Song HK, Thung SN, Rabinowitz J, Mandell L. Diminished ratio of estrogen receptors to progesterone receptors in breast carcinomas of women who have had multiple miscarriages. Mount Sinai J Med (NY) 1992;59:28-31. pdf

  49. Lehrer S, Levine E, Savoretti P, Cropley J, Thung SN, Mandell L, Shank B. Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 1992;339:1108-1109. pdf

  50. Macri P, Khoriaty G, Lehrer S, Karurunaratne A, Milne C, Schachter B. Sequence of a human estrogen receptor variant allele. Nucleic Acids Research 1992;20:2008 pdf

  51. Lehrer S, Levine E, Savoretti P, Cropley J, Song HK, Mandell LR, Shank B. Association of increased body mass index with diminished tumor estrogen receptor (ER) level in breast cancer patients younger than 50 years of age with ER-positive tumors. Cancer 1991;68:2489. pdf

  52. Schmutzler RK, Sanchez M, Lehrer S, Chaparro CA, Phillips C, Rabin J, Schachter B. Incidence of an estrogen receptor polymorphism in breast cancer patients. Breast Cancer Res Treat 1991;19:111-117. pdf

  53. Lehrer S, Sanchez M, Song HK, Dalton J, Levine E, Savoretti P, Thung SN, Schachter BS. Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet 1990;335:622-624. pdf

  54. Mencken the Welch-Basher. Hopkins Medical News. Summer 1990, p 3. pdf

  55. Garcia T, Sanchez M, Cox JL, Shaw PA, Ross JBA, Lehrer S, Schachter B. Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acids Research 1989;17:8364  pdf

  56. Lehrer S, O'Shaughnessy J, Song HK, Levine E, Savoretti P, Dalton J, Lipsztein R, Kalnicki S, Bloomer WD. Activity of pp60c-src protein kinase in human breast cancer. Mt Sinai J Med 1989;56:83-5. pdf

  57. Lehrer S, Diamond E, Song HK, Bloomer WD, Blumenthal R. Diminished corticosterone levels in nude mice implanted with MCF-7 or ZR-75-1 human breast tumor cells. Arch Gynecol Obstet 1989;245:704-7. pdf

  58. Garcia T, Lehrer S, Bloomer WD, Schachter B. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol 1988;2:785-91. pdf

  59. Lehrer S, Brown RR, Lee C, Kalnicki S, Lipsztein R, Bloomer WD. Neuroendocrine abnormalities and the pathogenesis of estrogen-receptor-positive breast cancer. Mt Sinai J Med 1988;55:272-5. abstract  pdf

  60. Lehrer S, Brown RR, Lee CM, Song HK, Kalnicki S, Lipsztein R, Dalton J, Bloomer WD. Tryptophan metabolism in women with breast cancer. Int J Cancer 1988;42:137. pdf

  61. Lehrer S, Levine E, Song HK, Bloomer WD. Breast size, endogenous estrogens, and breast cancer: a review with hypothesis. Mt Sinai J Med 1988;55:142-3. abstract  pdf

  62. Lehrer S. Rats on 22.5-hr light:dark cycles have vaginal opening earlier than rats on 26-hr light:dark cycles. J Pineal Res 1986;3:375-8.  abstract  pdf

  63. Lehrer S, Levine E, Bloomer WD. Abnormally diminished sense of smell in women with oestrogen receptor positive breast cancer. Lancet 1985;2:333.  pdf

  64. Lehrer S. Puberty and menopause in the human: possible relation to gonadotropin-releasing-hormone pulse frequency and the pineal gland. Pineal Research Reviews 1985;3:237-257. pdf

  65. Lehrer S. Modern correlates of Freudian psychology. Infant sexuality and the unconscious. Am J Med 1984;77:977-80. pdf

  66. Lehrer S. Puberty and resonance: a hypothesis. Mt Sinai J Med 1983;50:39-43. abstract  pdf

  67. Lehrer S. Fertility of blind women. Fertil Steril 1982;38:751-2. pdf

  68. Lehrer S. Life change and lung cancer. J Human Stress 1981;7:7-11. abstract  pdf

  69. Lehrer S. Twenty-one hour light-dark cycle accelerates vaginal opening in the rat. Bull N Y Acad Med 1981;57:705-8. pdf

  70. Lehrer S. Fertility and menopause in blind women. Fertil Steril 1981;36:396-8. pdf

  71. Lehrer S. Blindness increases life span of male rats: pineal effect on longevity. J Chronic Dis 1981;34:427-9. pdf

  72. Lehrer S. Telltale looks. Forbes. April 13, 1981. pdf

  73. Lehrer S. Life change and gastric cancer. Psychosom Med 1980;42:499-502. abstract  pdf

  74. Lehrer S. Clinical trial of rectal self-examination. Arch Intern Med 1979;139:1194.  pdf

  75. Lehrer S. Possible pineal-suprachiasmatic clock regulation of development and life span. Arch Ophthalmol 1979;97:359.

  76. Lehrer S. Pineal effect on longevity. J Chronic Dis 1979;32:411-2. pdf

  77. Lehrer S, Yoo OH, Roswit B, Jothikumar T. Mycosis fungoides with pulmanary manifestations. Mt Sinai J Med 1978;45:748-53.

  78. Lehrer S. Rectal self-examination. Am J Dig Dis 1978;23:572-3.

  79. Bryk D, Lehrer S. Successive abdominal roentgenograms: a new method of evaluating postoperative small bowel activity. Invest Radiol 1977;12:520-6.

  80. Lehrer S, Roswit B. Letter: Giant cell tumor of the temporal bone. Arch Neurol 1976;33:663.

  81. Lehrer S, Roswit B, Federman Q. The presentation of malignant lymphoma in the oral cavity and pharynx. Oral Surg Oral Med Oral Pathol 1976;41:441-50.


     

Home